Drug Safety Evaluation
Individual chapters address specific approaches to evaluating hazards, including problems that are encountered and their solutions. Author Shayne Gad draws upon over twenty years of experience in toxicology, drug development, and risk assessment, explaining the scientific and philosophical bases for evaluating specific concerns (carcinogenicity, development toxicity, etc.) to provide both understanding and guidance for approaching new problems. Containing information specifically relevant to the pharmaceutical and biotechnology industries, Drug Safety Evaluation covers a wide variety of topics, including:
- Acute toxicity testing in pharmaceutical safety evaluation
- Safety assessment of inhalant drugs
- Immunotoxicology in pharmaceutical development
- Large animal studies
- Evaluation of human tolerance and safety in clinical trials
About the Author.
Strategy and Phasing for Drug Safety Evaluation in the Discovery and Development of Pharmaceuticals.
Regulation of Human Pharmaceutical Safety.
Information Sources: Building and Maintaining Data Files.
Screens in Safety and Hazard Assessments.
Acute Toxicity Testing in Drug Safety Evaluation.
Subchronic and Chronic Toxicity Studies.
Developmental and Reproductive Toxicity Testing.
Safety Assessment of Inhalant Drugs.
Irritation and Local Tissue Tolerance in Pharmaceutical Safety Assessment.
Special Concerns for the Preclinical Evaluation of Biotechnology Products.
Formulations, Routes, and Dosage Designs.
Occupational Toxicology in the Pharmaceutical Industry.
Immunotoxicology in Pharmaceutical Development.
Large Animal Studies.
The Application of In Vitro Techniques in Drug Safety Assessment.
Pharmacokinetics/Toxicokinetics in Drug Safety Evaluation.
Evaluation of Human Tolerance and Safety in Clinical Trials: Phase I and Beyond.
Postmarketing Safety Evaluation: Monitoring Assessing and Reporting of Adverse Drug Response (ADRs).
Statistics in Pharmaceutical Safety Assessment.
Appendix A: Selected Relatory and Toxicological Acronyms.
Appendix B: Definition of Terms and Lexicon of Clinical Observations in Nonclinical (Animal) Studies.
Appendix C: Notable Regulatory Internet Addresses.
Appendix D: Glossary of Terms used in Clinical Evaluation of Therapeutic Agents.
"Gad brings…25 years of experience...to this practical guide..." (SciTech Book News, Vol. 26, No. 2, June 2002)
"...offers an accumulation of facts and knowledge of a highly specialized and intense industry from an individual who has been successful in innovations and quality assurance...." (Veterinary and Human Toxicology, Vol. 45, No. 1, February 2003)
"...it is a substantial book and accordingly should be considered a definitive reference work in this branch of toxicology." (Journal of Applied Toxicology, March-April 2003)
"...a definitive guide for those in the pharmaceutical industry who need to know how their products are evaluated and approved." (Business Horizons, January-February 2003)
"This book provides excellent treatise on drug safety evaluation...an excellent guide and reference..." (Pharmaceutical Research, Vol. 20, No. 6, June 2003)